Total Payments
$23,073
2023 Payments
$4,298
Companies
11
Transactions
34
Medicare Patients
1,125
Medicare Billing
$103,565
Payment Breakdown by Category
Consulting$21,546 (93.4%)
Food & Beverage$898.36 (3.9%)
Travel$564.82 (2.4%)
Other$64.15 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $21,546 | 11 | 93.4% |
| Food and Beverage | $898.36 | 11 | 3.9% |
| Travel and Lodging | $564.82 | 9 | 2.4% |
| Entertainment | $64.15 | 3 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $7,500 | 5 | $0 (2022) |
| Celgene Corporation | $4,346 | 4 | $0 (2019) |
| Janssen Scientific Affairs, LLC | $4,298 | 3 | $0 (2023) |
| GENZYME CORPORATION | $3,402 | 10 | $0 (2021) |
| Astellas Pharma US Inc | $1,922 | 2 | $0 (2018) |
| Progenics Pharmaceuticals, Inc. | $1,260 | 1 | $0 (2021) |
| C. R. Bard, Inc. & Subsidiaries | $186.80 | 3 | $0 (2017) |
| Hitachi Healthcare Americas Corp. | $64.15 | 3 | $0 (2018) |
| Koelis Inc. | $51.53 | 1 | $0 (2018) |
| CONMED Corporation | $23.33 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $4,298 | 3 | Janssen Scientific Affairs, LLC ($4,298) |
| 2022 | $1,750 | 1 | ABBVIE INC. ($1,750) |
| 2021 | $6,936 | 4 | AbbVie Inc. ($3,000) |
| 2020 | $1,250 | 1 | AbbVie Inc. ($1,250) |
| 2019 | $5,686 | 9 | Celgene Corporation ($3,746) |
| 2018 | $2,893 | 9 | Astellas Pharma US Inc ($1,922) |
| 2017 | $260.02 | 7 | C. R. Bard, Inc. & Subsidiaries ($186.80) |
All Payment Transactions
34 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2023 | Janssen Scientific Affairs, LLC | — | Travel and Lodging | Cash or cash equivalent | $68.15 | General |
| 12/14/2023 | Janssen Scientific Affairs, LLC | — | Consulting Fee | Cash or cash equivalent | $4,095.00 | General |
| 11/28/2023 | Janssen Scientific Affairs, LLC | — | Food and Beverage | In-kind items and services | $135.00 | General |
| 04/07/2022 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $1,750.00 | General |
| 12/30/2021 | Progenics Pharmaceuticals, Inc. | PYLARIFY (Drug) | Consulting Fee | Cash or cash equivalent | $1,260.00 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 09/09/2021 | AbbVie Inc. | — | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| 07/21/2021 | GENZYME CORPORATION | JEVTANA (Drug) | Consulting Fee | Cash or cash equivalent | $2,676.00 | General |
| Category: Oncology | ||||||
| 02/04/2021 | AbbVie Inc. | — | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| 06/29/2020 | AbbVie Inc. | — | Consulting Fee | Cash or cash equivalent | $1,250.00 | General |
| 10/24/2019 | GENZYME CORPORATION | NO PRODUCT DISCUSSED (Drug) | Travel and Lodging | In-kind items and services | $159.79 | General |
| 10/24/2019 | GENZYME CORPORATION | NO PRODUCT DISCUSSED (Drug) | Food and Beverage | In-kind items and services | $126.84 | General |
| 10/24/2019 | GENZYME CORPORATION | NO PRODUCT DISCUSSED (Drug) | Travel and Lodging | Cash or cash equivalent | $115.20 | General |
| 10/24/2019 | GENZYME CORPORATION | NO PRODUCT DISCUSSED (Drug) | Travel and Lodging | Cash or cash equivalent | $24.00 | General |
| 10/24/2019 | GENZYME CORPORATION | NO PRODUCT DISCUSSED (Drug) | Travel and Lodging | Cash or cash equivalent | $14.40 | General |
| 02/13/2019 | Celgene Corporation | CC-90011 (Drug) | Consulting Fee | Cash or cash equivalent | $3,600.00 | General |
| 02/13/2019 | Celgene Corporation | CC-90011 (Drug) | Food and Beverage | Cash or cash equivalent | $110.09 | General |
| 02/13/2019 | Celgene Corporation | CC-90011 (Drug) | Travel and Lodging | Cash or cash equivalent | $35.50 | General |
| 01/24/2019 | AbbVie, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| 11/12/2018 | Hitachi Healthcare Americas Corp. | — | Entertainment | Cash or cash equivalent | $33.38 | General |
| 10/26/2018 | GENZYME CORPORATION | NO PRODUCT DISCUSSED (Drug) | Food and Beverage | In-kind items and services | $138.23 | General |
| 10/26/2018 | GENZYME CORPORATION | NO PRODUCT DISCUSSED (Drug) | Travel and Lodging | Cash or cash equivalent | $107.59 | General |
| 10/26/2018 | GENZYME CORPORATION | NO PRODUCT DISCUSSED (Drug) | Travel and Lodging | Cash or cash equivalent | $25.00 | General |
| 10/26/2018 | GENZYME CORPORATION | NO PRODUCT DISCUSSED (Drug) | Travel and Lodging | Cash or cash equivalent | $15.19 | General |
| 10/25/2018 | Koelis Inc. | Trinity 3D Prostate Suite (Device) | Food and Beverage | In-kind items and services | $51.53 | General |
| Category: Urology | ||||||
| 02/10/2018 | Celgene Corporation | Abraxane (Drug) | Consulting Fee | Cash or cash equivalent | $600.00 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 15 | 591 | 616 | $408,039 | $54,114 |
| 2020 | 14 | 534 | 573 | $394,851 | $49,451 |
Total Patients
1,125
Total Services
1,189
Medicare Billing
$103,565
Procedure Codes
29
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 55875 | Insertion of needles or catheters into prostate for radiation therapy | Facility | 2021 | 25 | 25 | $111,050 | $15,350 | 13.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 175 | 192 | $45,814 | $8,527 | 18.6% |
| 55700 | Biopsy of prostate gland | Facility | 2021 | 57 | 59 | $48,675 | $5,906 | 12.1% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 32 | 32 | $22,912 | $4,110 | 17.9% |
| 55706 | Needle stereotactic and image-guided biopsy of prostate gland | Facility | 2021 | 11 | 11 | $22,792 | $3,096 | 13.6% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Facility | 2021 | 54 | 54 | $17,226 | $3,044 | 17.7% |
| 76498 | Mri scan | Facility | 2021 | 41 | 42 | $56,574 | $2,865 | 5.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 20 | 20 | $10,960 | $1,855 | 16.9% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 16 | 16 | $8,291 | $1,855 | 22.4% |
| 52000 | Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | Facility | 2021 | 28 | 32 | $20,864 | $1,816 | 8.7% |
| 76873 | Ultrasound of prostate through rectum for radiation therapy planning | Facility | 2021 | 25 | 25 | $12,800 | $1,515 | 11.8% |
| 76965 | Ultrasonic guidance for administration of radiation therapy | Facility | 2021 | 25 | 25 | $11,050 | $1,323 | 12.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 16 | 16 | $5,909 | $1,260 | 21.3% |
| 76942 | Ultrasonic guidance imaging supervision and interpretation for insertion of needle | Facility | 2021 | 52 | 53 | $11,713 | $1,250 | 10.7% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Facility | 2021 | 14 | 14 | $1,409 | $341.52 | 24.2% |
| 55875 | Insertion of needles or catheters into prostate for radiation therapy | Facility | 2020 | 34 | 34 | $151,028 | $20,761 | 13.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 155 | 185 | $42,937 | $6,465 | 15.1% |
| 55700 | Biopsy of prostate gland | Facility | 2020 | 66 | 66 | $54,450 | $6,327 | 11.6% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 33 | 33 | $23,812 | $4,043 | 17.0% |
| 76873 | Ultrasound of prostate | Facility | 2020 | 34 | 34 | $17,408 | $2,108 | 12.1% |
| 52000 | Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | Facility | 2020 | 28 | 37 | $24,864 | $2,071 | 8.3% |
| 76965 | Ultrasonic guidance for administration of radiation therapy | Facility | 2020 | 34 | 34 | $15,028 | $1,832 | 12.2% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Facility | 2020 | 18 | 18 | $10,036 | $1,339 | 13.3% |
| 76942 | Ultrasonic guidance imaging supervision and interpretation for insertion of needle | Facility | 2020 | 53 | 53 | $11,713 | $1,246 | 10.6% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Facility | 2020 | 21 | 21 | $6,959 | $1,089 | 15.7% |
About Dr. Eric Klein, MD
Dr. Eric Klein, MD is a Urology healthcare provider based in Cleveland, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1780649764.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eric Klein, MD has received a total of $23,073 in payments from pharmaceutical and medical device companies, with $4,298 received in 2023. These payments were reported across 34 transactions from 11 companies. The most common payment nature is "Consulting Fee" ($21,546).
As a Medicare-enrolled provider, Klein has provided services to 1,125 Medicare beneficiaries, totaling 1,189 services with total Medicare billing of $103,565. Data is available for 2 years (2020–2021), covering 29 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Cleveland, OH
- Active Since 04/20/2006
- Last Updated 02/12/2008
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1780649764
Products in Payments
- CC-90011 (Drug) $3,746
- JEVTANA (Drug) $2,676
- ENZALUTAMIDE (Drug) $1,922
- PYLARIFY (Drug) $1,260
- NO PRODUCT DISCUSSED (Drug) $726.24
- Abraxane (Drug) $600.00
- BMD-Solo Guidewire (Device) $151.64
- Trinity 3D Prostate Suite (Device) $51.53
- BMD-Brachysource I-25 seed (Device) $35.16
- Oasis MRI System (Device) $30.77
- AirSeal (Device) $23.33
- Axumin (Drug) $19.12
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Cleveland
Howard Goldman, Md, MD
Urology — Payments: $688,743
Urology $688,743
Jihad Kaouk, Md, MD
Urology — Payments: $258,551
Urology $258,551
Sandip Vasavada, Md, MD
Urology — Payments: $247,878
Urology $247,878
Petar Bajic, M.d, M.D
Urology — Payments: $238,227
Urology $238,227
Dr. Sriharan Sivalingam, Md, MD
Urology — Payments: $210,140
Urology $210,140
Ruben Olivares, Md, MD
Urology — Payments: $174,034
Urology $174,034